GLSI
NASDAQ
$14.07
Greenwich LifeSciences Inc (GLSI)
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for breast and other HER2 / neu-expressing cancers. The company is headquartered in Stafford, Texas.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $47.50 (+237.60%)
Market Cap
$287M
Free Cash Flow Yield
-4.46%
Beta (5Y)
1.49
Price Chart
Valuation
Market Cap$287M
P/B53.00
Profitability
EBITDA-$22M
EPS-$1.58
Financial Health
Free Cash Flow Yield-4.46%
Growth & Risk
Beta (5Y)1.49
Sharpe Ratio0.58